DIA412.42-1.46 -0.35%
SPX5,659.91-4.03 -0.07%
IXIC17,928.92+0.78 0.00%

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga·04/28/2025 12:12:57
Listen to the news

Gainers

  • Portage Biotech (NASDAQ:PRTG) shares increased by 49.2% to $12.61 during Monday's pre-market session. The market value of their outstanding shares is at $20.7 million.
  • CG Oncology (NASDAQ:CGON) stock rose 43.49% to $32.1. The company's market cap stands at $2.4 billion.
  • Bionano Genomics (NASDAQ:BNGO) stock rose 30.93% to $5.63. The market value of their outstanding shares is at $15.3 million.
  • Tharimmune (NASDAQ:THAR) shares moved upwards by 23.34% to $1.48. The market value of their outstanding shares is at $2.8 million.
  • Autonomix Medical (NASDAQ:AMIX) shares increased by 16.78% to $2.43. The market value of their outstanding shares is at $5.9 million.
  • 60 Degrees (NASDAQ:SXTP) shares moved upwards by 12.54% to $3.32. The company's market cap stands at $4.8 million.

Losers

  • Spruce Biosciences (NASDAQ:SPRB) shares fell 32.7% to $0.09 during Monday's pre-market session. The market value of their outstanding shares is at $3.6 million.
  • Inspire Veterinary (NASDAQ:IVP) stock declined by 22.09% to $1.27. The company's market cap stands at $1.8 million.
  • Zynex (NASDAQ:ZYXI) shares declined by 14.94% to $2.05. The market value of their outstanding shares is at $61.9 million.
  • Salarius Pharmaceuticals (NASDAQ:SLRX) stock decreased by 12.66% to $0.64. The company's market cap stands at $1.3 million.
  • Abpro Hldgs (NASDAQ:ABP) shares declined by 12.62% to $0.28. The company's market cap stands at $14.5 million.
  • Upstream Bio (NASDAQ:UPB) shares declined by 9.3% to $7.61. The company's market cap stands at $408.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.